Cardinal Health, Inc. $CAH Position Lessened by Ironwood Investment Counsel LLC

Ironwood Investment Counsel LLC trimmed its stake in Cardinal Health, Inc. (NYSE:CAH) by 20.4% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 25,218 shares of the company’s stock after selling 6,447 shares during the quarter. Ironwood Investment Counsel LLC’s holdings in Cardinal Health were worth $3,958,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Norges Bank acquired a new stake in shares of Cardinal Health in the second quarter valued at approximately $584,420,000. Acadian Asset Management LLC grew its holdings in Cardinal Health by 92.5% in the 2nd quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock worth $282,063,000 after buying an additional 807,063 shares in the last quarter. Prudential Financial Inc. increased its position in Cardinal Health by 476.8% in the 2nd quarter. Prudential Financial Inc. now owns 883,348 shares of the company’s stock valued at $148,402,000 after acquiring an additional 730,209 shares during the period. Voya Investment Management LLC raised its stake in Cardinal Health by 298.3% during the 3rd quarter. Voya Investment Management LLC now owns 821,723 shares of the company’s stock valued at $128,978,000 after acquiring an additional 615,398 shares in the last quarter. Finally, AustralianSuper Pty Ltd raised its stake in Cardinal Health by 237.6% during the 3rd quarter. AustralianSuper Pty Ltd now owns 680,173 shares of the company’s stock valued at $106,760,000 after acquiring an additional 478,689 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

NYSE CAH opened at $226.85 on Friday. Cardinal Health, Inc. has a 12 month low of $120.72 and a 12 month high of $230.81. The company has a market capitalization of $53.90 billion, a P/E ratio of 32.64, a PEG ratio of 1.51 and a beta of 0.64. The company’s 50 day simple moving average is $206.92 and its 200 day simple moving average is $179.97.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, February 5th. The company reported $2.63 earnings per share for the quarter, topping analysts’ consensus estimates of $2.31 by $0.32. The firm had revenue of $65.63 billion during the quarter, compared to analysts’ expectations of $64.88 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The firm’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same period last year, the firm posted $1.93 earnings per share. On average, analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Leerink Partners raised their price target on Cardinal Health from $240.00 to $268.00 and gave the company an “outperform” rating in a report on Thursday. UBS Group set a $260.00 target price on shares of Cardinal Health and gave the company a “buy” rating in a research note on Friday. Morgan Stanley set a $255.00 price target on shares of Cardinal Health in a research report on Friday. TD Cowen reiterated a “buy” rating on shares of Cardinal Health in a report on Tuesday, January 27th. Finally, Evercore ISI reissued an “outperform” rating on shares of Cardinal Health in a report on Thursday. Fifteen analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $239.93.

Key Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Q2 results and raised outlook — Cardinal reported Q2 FY2026 revenue up ~19% to $65.6B and non‑GAAP EPS of $2.63 (beat), and raised fiscal‑year non‑GAAP EPS guidance to $10.15–$10.35; management cited strong specialty medicine demand and improved segment performance. PR Newswire
• Positive Sentiment: Analyst upgrade and price‑target lift — Leerink Partners raised its price target from $240 to $268 and kept an outperform rating, signaling more upside from current levels. MarketScreener
• Positive Sentiment: Street commentary and momentum coverage — Multiple outlets (Barron’s, Reuters, Zacks, TipRanks, 24/7 Wall St.) highlight the beat, raised guidance and accelerating specialty drug volumes, which has driven momentum interest in the stock. Examples: Reuters coverage on the outlook and Barron’s note on guidance lifts. Reuters
• Neutral Sentiment: Earnings call & transcripts available — Management commentary and slides from the Q2 call confirm the drivers behind the beat (specialty medicine, margin expansion, buybacks); these provide detail but no new surprises beyond the release. MSN Transcript
• Neutral Sentiment: Momentum stock analysis — Zacks highlights style‑score based momentum attributes, which can attract technical and quant funds but also increase volatility. Zacks
• Negative Sentiment: Valuation and historical ROE signal — After the rally the stock trades at an elevated P/E (~34x) and company data show a negative trailing return on equity metric, which could concern value‑focused investors and limit upside absent continued execution. Background valuation metrics

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.